RSMDF — RESMED INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 943819 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,414,814,000 | 870,567,000 | 452,984,000 | 418,413,000 | 8,211,811,000 | 1,010,742,000 | 2,264,121,000 |
| Jun 2026 | 1,463,647,000 | 861,219,000 | 448,712,000 | 383,432,000 | 8,965,950,000 | 1,469,234,000 | 2,380,557,000 |
| Mar 2026 | 1,431,406,000 | 890,979,000 | 499,810,000 | 398,732,000 | 8,784,285,000 | 1,660,513,000 | 2,292,374,000 |
| Dec 2025 | 1,422,808,000 | 878,724,000 | 497,595,000 | 392,593,000 | 8,503,370,000 | 1,417,069,000 | 2,182,491,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,805,829,000
Investing CF
$-545,199,000
Financing CF
$-1,007,029,000
CapEx
$-177,173,000
Dividends Paid
$-349,662,000
Buybacks
$-700,037,000
EPS Diluted TTM
$1.06
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$7,255,121,000
Inventory
$945,805,000
Receivables
$1,084,953,000
ST Investments
—
EBIT TTM
$1,908,464,000
Pretax Income TTM
$1,919,417,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,732,675,072
EBITDA
$2,096,264,960
Free Cash Flow
$1,274,890,624
Enterprise Value
$13,727,149,056
Total Cash
$1,010,742,016
Total Debt
$610,577,984
Shares Out
1,406,570,710
Trailing EPS
$1.10
Book Value
$10.40
ROE
26.4%
ROA
14.6%
Div Yield
10.69%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 5,653,443,000 | 1,908,460,000 | 1,523,293,000 | 8,970,000,000 | 2,380,000,000 | 6,585,393,000 | 1,805,829,000 |
| Jun 2025 | 5,146,327,000 | 1,685,363,000 | 1,400,723,000 | 8,170,000,000 | 2,206,532,000 | 5,967,859,000 | 1,751,588,000 |
| Jun 2024 | 4,685,297,000 | 1,384,121,000 | 1,020,951,000 | 6,870,000,000 | 2,008,351,000 | 4,864,043,000 | 1,401,260,000 |
| Jun 2023 | 4,222,993,000 | 1,151,997,000 | 897,556,000 | 6,750,000,000 | 2,621,805,000 | 4,129,903,000 | 693,299,000 |
TTM Snapshot
Revenues TTM
$5,653,443,000
NetIncome TTM
$1,523,293,000
OpCashFlow TTM
—
Assets (Latest)
$8,784,285,000
Forward EPS
$0.41
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $152.10B | $430.53 | — |
| MDT | Medtronic plc | $130.88B | $102.32 | — |
| SYK | STRYKER CORP | $120.88B | $317.54 | — |
| MMM | 3M CO | $93.28B | $180.88 | — |
| BSX | BOSTON SCIENTIFIC CORP | $62.37B | $43.03 | — |
News headlines (Yahoo Finance, 1h cache)
Global Virtual Sleep Clinics Market Report 2026: Forecast to 2030 | Capitalize on AI Diagnostics and Home Testing: ResMed, Philips, Teladoc, and Oura Drive Market to $3.46 Billion
2026-11-18 14:34 · Yahoo
Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?
2026-11-13 15:15 · Yahoo
Oura makes bet on AI in healthcare with $625M Counsel Health buy
2026-11-11 16:38 · Yahoo
INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?
2026-11-10 18:31 · Yahoo
Don’t Lose Sleep Over GLP-1s: Why ResMed Stock Is a Bargain
2026-11-07 03:04 · Yahoo
ResMed: 3 Key Takeaways for Long-Term Investors
2026-11-02 09:33 · Yahoo
What Sent ResMed Stock Lower?
2026-11-02 01:23 · Yahoo
RMD Q3 deep dive: product innovation and supply chain execution drive results amid evolving landscape
2026-10-31 23:07 · Yahoo
ResMed (RMD) Looks Fully Valued After Another Earnings Beat
2026-10-30 19:16 · Yahoo
ResMed (RMD) Q1 2027 Earnings Call Transcript
2026-10-30 15:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.